4.6 Review

Interferon Response and Viral Evasion by Members of the Family Rhabdoviridae

期刊

VIRUSES-BASEL
卷 1, 期 3, 页码 832-851

出版社

MDPI AG
DOI: 10.3390/v1030832

关键词

rhabdovirus; interferon; rabies virus; vesicular stomatitis virus

类别

向作者/读者索取更多资源

Like many animal viruses, those of the Rhabdoviridae family, are able to antagonize the type I interferon response and cause disease in mammalian hosts. Though these negative-stranded RNA viruses are very simple and code for as few as five proteins, they have been seen to completely abrogate the type I interferon response early in infection. In this review, we will discuss the viral organization and type I interferon evasion of rhabdoviruses, focusing on vesicular stomatitis virus (VSV) and rabies virus (RABV). Despite their structural similarities, VSV and RABV have completely different mechanisms by which they avert the host immune response. VSV relies on the matrix protein to interfere with host gene transcription and nuclear export of anti-viral mRNAs. Alternatively, RABV uses its phosphoprotein to interfere with IRF-3 phosphorylation and STAT1 signaling. Understanding the virus-cell interactions and viral proteins necessary to evade the immune response is important in developing effective vaccines and therapeutics for this viral family.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies

Shuyun Qin, Dmitriy Volokhov, Elvira Rodionova, Christoph Wirblich, Matthias J. Schnell, Vladimir Chizhikov, Alena Dabrazhynetskaya

BIOLOGICALS (2019)

Editorial Material Immunology

Avoiding preventable deaths: The scourge of counterfeit rabies vaccines

Emma Taylor, Ashley C. Banyard, Herve Bourhy, Florence Cliquet, Hildegund Ertl, Christine Fehlner-Gardiner, Daniel L. Horton, Reeta S. Mani, Thomas Mueller, Charles E. Rupprecht, Matthias J. Schnell, Victor Del Rio Vilas, Anthony R. Fooks

VACCINE (2019)

Article Immunology

Rabies-based vaccine induces potent immune responses against Nipah virus

Rohan Keshwara, Thomas Shiels, Elena Postnikova, Drishya Kurup, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell

NPJ VACCINES (2019)

Correction Immunology

Rabies-based vaccine induces potent immune responses against Nipah virus (vol 4, 15, 2019)

Rohan Keshwara, Thomas Shiels, Elena Postnikova, Drishya Kurup, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell

NPJ VACCINES (2019)

Article Surgery

Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer

Gwenyth L. Day, Michelle L. Bryan, Scott A. Northrup, Douglas S. Lyles, Marlena M. Westcott, John H. Stewart

JOURNAL OF SURGICAL RESEARCH (2020)

Article Virology

Identification and Characterization of a Small -Molecule Rabies Virus Entry Inhibitor

Venice Du Pont, Christoph Wirblich, Jeong-Joong Yoon, Robert M. Cox, Matthias J. Schnell, Richard K. Plemper

JOURNAL OF VIROLOGY (2020)

Article Oncology

MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells

Robert S. Bayne, Shelby Puckett, Lindsey Ulkus Rodrigues, Scott D. Cramer, Jingyun Lee, Cristina M. Furdui, Jeff W. Chou, Lance D. Miller, David A. Ornelles, Douglas S. Lyles

MOLECULAR THERAPY-ONCOLYTICS (2020)

Article Immunology

Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2

Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J. Schnell

NPJ VACCINES (2020)

Article Virology

Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization

Nisha Asok Kumar, Sreenath Muraleedharan Suma, Umerali Kunnakkadan, Joydeep Nag, Reshma Koolaparambil Mukesh, Douglas S. Lyles, John Bernet Johnson

Summary: This study found that VSV infection resulted in down-regulation of CD46 protein, but not CD55, and the mRNA of RCAs was significantly down-regulated by VSV, but with a delay in the case of CD55. Immunoblot analysis showed an equal distribution ratio of CD55 and CD46 relative to viral proteins in the progeny virion harvested at specific time intervals.

VIRUSES-BASEL (2021)

Article Microbiology

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model

Drishya Kurup, Delphine C. Malherbe, Christoph Wirblich, Rachael Lambert, Adam J. Ronk, Leila Zabihi Diba, Alexander Bukreyev, Matthias J. Schnell

Summary: The study developed an inactivated rabies virus vectored vaccine platform, resulting in a vaccine against SARS-CoV-2 named CORAVAX. CORAVAX demonstrated effectiveness in preventing viral replication and lung disease in hamster models, showing potential for robust immune responses in humans.

PLOS PATHOGENS (2021)

Article Immunology

Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract

Drishya Kurup, Christoph Wirblich, Rachael Lambert, Leila Zabihi Diba, Benjamin E. Leiby, Matthias J. Schnell

Summary: The study showed that a measles vaccine expressing both ZIKV-E and -NS1 provided complete clearance of the virus and full protection for fetuses in a lethal Zika challenge model. NS1 antibodies were found to enhance the protective effects of ZIKV-E antibodies in the female reproductive tract.

NPJ VACCINES (2022)

Article Virology

Dynamic Actin Filament Traps Mediate Active Diffusion of Vesicular Stomatitis Virus Ribonucleoproteins

Steven J. Moran, Shelby Puckett, David A. Ornelles, Jed C. Macosko, George Holzwarth, Douglas S. Lyles

Summary: A recent study using pattern recognition and machine learning analyzed the movement of single viral ribonucleoprotein particles in living cells and provided a quantitative molecular explanation for active diffusion. The study found that these particles are temporarily confined to traps or pores formed by cytoskeletal elements, and active diffusion occurs when they escape from one trap to another. This research has important implications for understanding the motion of other viral and cellular elements.

JOURNAL OF VIROLOGY (2022)

Article Immunology

Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity

Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J. Schnell

Summary: The objective of this study is to analyze the effectiveness of the recombinant rabies virus-vectored SARS-CoV-2 vaccine, CORAVAX, as a COVID-19 vaccine strategy. The study found that CORAVAX is immunogenic and protective against SARS-CoV-2, and it addresses the issue of waning immunity seen in other COVID-19 vaccines. By selecting the right adjuvants and tackling pre-existing rabies-vector immunity, CORAVAX has shown long-term potential as a COVID-19 vaccine.

NPJ VACCINES (2022)

Article Immunology

Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J. Schnell

Summary: Ebola virus is a major cause of severe hemorrhagic fever with a high mortality rate. An Ebola virus glycoprotein expressing inactivated bivalent filovirus/rabies virus vaccine called FILORAB1 has shown immunogenicity and protection against Ebola virus in mice and non-human primates, especially when formulated with toll-like receptor 4 agonist GLA and squalene oil-in-water emulsion. The immune response to FILORAB1 is long-lasting and characterized by maintained serum antibody titers and long-lived cells in the spleen and bone marrow.

NPJ VACCINES (2023)

Article Immunology

GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus

Gabrielle Scher, Dennis A. Bente, Megan C. Mears, Maria N. B. Cajimat, Matthias J. Schnell

Summary: Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic disease in humans. Recent research has shown that a monoclonal antibody against the GP38 glycoprotein can protect mice from lethal CCHFV infection. In this study, three inactivated rhabdoviral-based CCHFV-M vaccines were tested, and only the vaccines containing GP38 provided protection against CCHFV challenge in mice.

NPJ VACCINES (2023)

暂无数据